1. Home
  2. ACRS vs SPIR Comparison

ACRS vs SPIR Comparison

Compare ACRS & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.06

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Logo Spire Global Inc.

SPIR

Spire Global Inc.

HOLD

Current Price

$9.58

Market Cap

292.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
SPIR
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
311.0M
292.9M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ACRS
SPIR
Price
$3.06
$9.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$9.75
$13.10
AVG Volume (30 Days)
1.2M
432.2K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
69.01
N/A
EPS
N/A
2.31
Revenue
$1,683,000.00
$110,451,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.07
P/E Ratio
N/A
$4.22
Revenue Growth
N/A
13.15
52 Week Low
$1.05
$6.60
52 Week High
$4.89
$14.53

Technical Indicators

Market Signals
Indicator
ACRS
SPIR
Relative Strength Index (RSI) 43.84 49.44
Support Level $2.78 $8.71
Resistance Level $3.46 $12.41
Average True Range (ATR) 0.21 0.62
MACD -0.03 0.07
Stochastic Oscillator 44.53 67.55

Price Performance

Historical Comparison
ACRS
SPIR

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: